Expanding live donor kidney transplantation through advocacy training and social media
通过宣传培训和社交媒体扩大活体肾移植
基本信息
- 批准号:9923125
- 负责人:
- 金额:$ 8.84万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2017
- 资助国家:美国
- 起止时间:2017-04-01 至 2022-03-31
- 项目状态:已结题
- 来源:
- 关键词:AddressAdoptionAdultAdvocacyAfrican AmericanAmericanAwarenessCaringCaucasiansCessation of lifeCharacteristicsChronicClinicalCollaborationsCommunicationCommunitiesCountryDataDevelopmentDonor personEducationEffectivenessEnd stage renal failureEnrollmentEthnic OriginEvaluationEventFacebookFamily memberFocus GroupsFriendsFutureGroup InterviewsHeterogeneityHispanic AmericansHispanicsIncidenceIndividualInterventionKidneyKidney TransplantationKnowledgeLeadershipLinkMidwestern United StatesOrganOutcomeParticipantPatientsPersonsPilot ProjectsPopulationPopulation HeterogeneityProtocols documentationRaceRandomizedRandomized Controlled TrialsResourcesRiskSocial NetworkSocietiesSubgroupSurvival AnalysisTestingTimeTrainingTraining ProgramsTransplant SurgeonTransplantationUnited Network for Organ SharingUnited StatesViralWaiting Listsarmclinical carecomparative effectivenessdesignmembernovelpatient populationprimary outcomeprogramsprospectivepublic health relevancesocial mediastandard of caretransplant centerstreatment effecttrial comparing
项目摘要
Summary
Over 90,000 individuals in the United States await kidney transplantation. Only about 12,000 will receive a
deceased donor transplant each year, and recent efforts to increase deceased donation have been largely
unsuccessful. As a result, most candidates on the waiting list have a higher chance of dying than of being
offered a deceased donor kidney. Live donor kidney transplantation (LDKT) eliminates the wait and offers
superior survival, but accounts for fewer than 6,000 additional transplants per year despite a huge potential
pool of millions of adults living in the US. Worse, LDKT rates are lowest among Hispanic and African American
candidates who account for over 30% of the waitlist. Regardless of race, known barriers to identifying a live
donor include lack of education, reluctance to discuss one's illness, and hesitance to ask others to donate.
We have developed two novel interventions to address these barriers. The first is a 6-month training program
that combines education, advocacy, and instrumental support by pairing candidates with a live donor champion
(LDC): a friend, family member, or community member trained to spread awareness of ESRD, LDKT, and the
candidate's story throughout their social network. The second is a less-intensive Facebook (FB) app (designed
in collaboration with FB leadership) that leverages the broad reach of social media to spread awareness,
facilitating FB posts about the candidate's story, providing links to education about ESRD and LDKT, and
documenting the candidate's search for a donor through a "chronically viral" Facebook story.
In pilot studies at our center, participants of both interventions were significantly more likely to undergo LDKT
compared to matched controls. While encouraging, pilot testing has been non-randomized and limited to our
center and its unique patient population. Furthermore, it remains unclear how intense an intervention is
necessary, i.e. the less-intense FB approach or the more-intense champion approach. To assess the real-
world effectiveness of the LDC program and/or the Facebook app in expanding live donation among a
heterogeneous population of waitlist candidates, we now propose to test these interventions at three busy
transplant centers that serve a heterogeneous group of largely underserved patients.
The relative dearth of deceased donors has caused a profound organ shortage; it is essential to turn to novel
efforts that increase live donation. Development and widespread implementation of culturally competent LDC
and Facebook App interventions has the potential to increase the overall incidence of LDKT while also
addressing disparities in access to LDKT.
总结
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
ANDREW M. CAMERON其他文献
ANDREW M. CAMERON的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('ANDREW M. CAMERON', 18)}}的其他基金
Development of an Interactive Bioethics Training Module for Healthcare Providers Treating Patients Who Need Liver Transplant for Alcohol-associated Liver Disease
为治疗酒精相关性肝病需要肝移植的患者的医疗保健提供者开发交互式生物伦理学培训模块
- 批准号:
10785093 - 财政年份:2023
- 资助金额:
$ 8.84万 - 项目类别:
Multidisciplinary approach to study of patients with Severe Alcoholic Hepatitis Undergoing Liver Transplantation
多学科方法对接受肝移植的重症酒精性肝炎患者进行研究
- 批准号:
10560540 - 财政年份:2019
- 资助金额:
$ 8.84万 - 项目类别:
Project 1-Cohort and Ethical Analysis of Patients undergoing Early Liver Transplant for Severe Alcoholic Hepatitis
项目1-严重酒精性肝炎早期肝移植患者的队列和伦理分析
- 批准号:
10356013 - 财政年份:2019
- 资助金额:
$ 8.84万 - 项目类别:
Project 1-Cohort and Ethical Analysis of Patients undergoing Early Liver Transplant for Severe Alcoholic Hepatitis
项目1-严重酒精性肝炎早期肝移植患者的队列和伦理分析
- 批准号:
10560558 - 财政年份:2019
- 资助金额:
$ 8.84万 - 项目类别:
Multidisciplinary approach to study of patients with Severe Alcoholic Hepatitis Undergoing Liver Transplantation
多学科方法对接受肝移植的重症酒精性肝炎患者进行研究
- 批准号:
10356010 - 财政年份:2019
- 资助金额:
$ 8.84万 - 项目类别:
Multidisciplinary approach to study of patients with Severe Alcoholic Hepatitis Undergoing Liver Transplantation
多学科方法对接受肝移植的重症酒精性肝炎患者进行研究
- 批准号:
10093975 - 财政年份:2019
- 资助金额:
$ 8.84万 - 项目类别:
相似海外基金
WELL-CALF: optimising accuracy for commercial adoption
WELL-CALF:优化商业采用的准确性
- 批准号:
10093543 - 财政年份:2024
- 资助金额:
$ 8.84万 - 项目类别:
Collaborative R&D
Investigating the Adoption, Actual Usage, and Outcomes of Enterprise Collaboration Systems in Remote Work Settings.
调查远程工作环境中企业协作系统的采用、实际使用和结果。
- 批准号:
24K16436 - 财政年份:2024
- 资助金额:
$ 8.84万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Unraveling the Dynamics of International Accounting: Exploring the Impact of IFRS Adoption on Firms' Financial Reporting and Business Strategies
揭示国际会计的动态:探索采用 IFRS 对公司财务报告和业务战略的影响
- 批准号:
24K16488 - 财政年份:2024
- 资助金额:
$ 8.84万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10107647 - 财政年份:2024
- 资助金额:
$ 8.84万 - 项目类别:
EU-Funded
Assessing the Coordination of Electric Vehicle Adoption on Urban Energy Transition: A Geospatial Machine Learning Framework
评估电动汽车采用对城市能源转型的协调:地理空间机器学习框架
- 批准号:
24K20973 - 财政年份:2024
- 资助金额:
$ 8.84万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10106221 - 财政年份:2024
- 资助金额:
$ 8.84万 - 项目类别:
EU-Funded
Our focus for this project is accelerating the development and adoption of resource efficient solutions like fashion rental through technological advancement, addressing longer in use and reuse
我们该项目的重点是通过技术进步加快时装租赁等资源高效解决方案的开发和采用,解决更长的使用和重复使用问题
- 批准号:
10075502 - 财政年份:2023
- 资助金额:
$ 8.84万 - 项目类别:
Grant for R&D
Engage2innovate – Enhancing security solution design, adoption and impact through effective engagement and social innovation (E2i)
Engage2innovate — 通过有效参与和社会创新增强安全解决方案的设计、采用和影响 (E2i)
- 批准号:
10089082 - 财政年份:2023
- 资助金额:
$ 8.84万 - 项目类别:
EU-Funded
De-Adoption Beta-Blockers in patients with stable ischemic heart disease without REduced LV ejection fraction, ongoing Ischemia, or Arrhythmias: a randomized Trial with blinded Endpoints (ABbreviate)
在没有左心室射血分数降低、持续性缺血或心律失常的稳定型缺血性心脏病患者中停用β受体阻滞剂:一项盲法终点随机试验(ABbreviate)
- 批准号:
481560 - 财政年份:2023
- 资助金额:
$ 8.84万 - 项目类别:
Operating Grants
Collaborative Research: SCIPE: CyberInfrastructure Professionals InnoVating and brOadening the adoption of advanced Technologies (CI PIVOT)
合作研究:SCIPE:网络基础设施专业人员创新和扩大先进技术的采用 (CI PIVOT)
- 批准号:
2321091 - 财政年份:2023
- 资助金额:
$ 8.84万 - 项目类别:
Standard Grant